Normal-pressure hydrocephalus: Is there a genetic predisposition?

Canadian Journal of Neurological Sciences

Volumn 38, Issue 2, 2011, Pages 274-281

  Cusimano, M D ^a   Rewilak, D ^b   Stuss, D T ^c,e   Barrera Martinez, J C ^c,e   Salehi, F ^a   Freedman, M ^c,d,e  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b BAYCREST CENTRE FOR GERIATRIC CARE   (Canada)

^c ROTMAN RESEARCH INSTITUTE   (Canada)

^d UNIVERSITY HEALTH NETWORK   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; APOLIPOPROTEIN E3; CALCIUM CARBONATE; CONJUGATED ESTROGEN; ENALAPRIL; RANITIDINE;

AGED; ARTICLE; CASE REPORT; CHROMOSOME 19; COGNITIVE DEFECT; ENVIRONMENTAL FACTOR; FEMALE; FOLLOW UP; GAIT DISORDER; GENETIC PREDISPOSITION; HOMOZYGOSITY; HUMAN; HYPERTENSION; MINI MENTAL STATE EXAMINATION; NEUROPSYCHOLOGICAL TEST; NORMOTENSIVE HYDROCEPHALUS; PATHOGENESIS; PRIORITY JOURNAL; TREATMENT OUTCOME; VASCULAR DISEASE;

EID: 79951733284     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/S031716710001146X     Document Type: Article

References (24)

1. Adams RD, Fisher CM, Hakim S, Ojemann RG, Sweet WH. Symptomatic occult hydrocephalus with "normal" cerebrospinalfluid pressure. A treatable syndrome. N Engl J Med. 1965;273: 117-26.
2. Hakim S, Adams RD. The special clinical problem of symptomatic hydrocephalus with normal cerebrospinal fluid pressure. observations on cerebrospinal fluid hydrodynamics. J Neurol Sci. 1965;2(4):307-27.
3. Vanneste J, Augustijn P, Davies GA, Dirven C, Tan WF. Normalpressure hydrocephalus. Is cisternography still useful in selecting patients for a shunt? Arch Neurol. 1992;49(4):366-70.
4. Earnest MP, Fahn S, Karp JH, Rowland LP. Normal pressure hydrocephalus and hypertensive cerebrovascular disease. Arch Neurol. 1974;31(4):262-6.
5. Hebb AO, Cusimano MD. Idiopathic normal pressure hydrocephalus: a systematic review of diagnosis and outcome. Neurosurgery. 2001;49(5):1166-84; discussion 1184-6.
6. Koto A, Rosenberg G, Zingesser LH, Horoupian D, Katzman R. Syndrome of normal pressure hydrocephalus: possible relation to hypertensive and arteriosclerotic vasculopathy. J Neurol Neurosurg Psychiatry. 1977;40(1):73-9. (Pubitemid 8050902)
7. Casmiro M, D'Alessandro R, Cacciatore FM, Daidone R, Calbucci F, Lugaresi E. Risk factors for the syndrome of ventricular enlargement with gait apraxia (idiopathic normal pressure hydrocephalus): a case-control study. J Neurol Neurosurg Psychiatry. 1989;52(7):847-52. (Pubitemid 19181342)
8. Chalmers RM, Andreae L, Wood NW, Durai Raj RV, Casey AT. Familial hydrocephalus. J Neurol Neurosurg Psychiatry. 1999;67 (3):410-1.
9. Christensen PB. Normal pressure hydrocephalus in myotonic dystrophy. Eur Neurol. 1988;28(5):285-7.
10. Katsuragi S, Teraoka K, Ikegami K, et al. Late onset X-linked hydrocephalus with normal cerebrospinal fluid pressure. Psychiatry Clin Neurosci. 2000;54(4):487-92.
11. Portenoy RK, Berger A, Gross E. Familial occurrence of idiopathic normal-pressure hydrocephalus. Arch Neurol. 1984;41(3):335-7. (Pubitemid 14198578)
12. Zhang J, Williams MA, Rigamonti D. Heritable essential tremoridiopathic normal pressure hydrocephalus (ETINPH).Am J Med Genet A. 2008;146A(4):433-9. (Pubitemid 351206813)
13. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of alzheimer's disease in late onset families. Science. 1993;261(5123):921-3. (Pubitemid 23275809)
14. Goodglass H, Kaplan E. Boston diagnostic aphasia examination (BDAE). Philadelphia: Lea and Febiger; 1983.
15. Gallassi R, Morreale A, Montagna P, Sacquegna T, Di Sarro R, Lugaresi E. Binswanger's disease and normal-pressure hydrocephalus. clinical and neuropsychological comparison. Arch Neurol. 1991 Nov;48(11):1156-9.
16. Darvesh S, Leach L, Black SE, Kaplan E, Freedman M. The behavioural neurology assessment. Can J Neurol Sci. 2005;32 (2):167-77. (Pubitemid 40839958)
17. Saunders AM, Strittmatter WJ, Schmechel D, et al. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic alzheimer's disease. Neurology. 1993;43(8):1467-72. (Pubitemid 23230526)
18. Nacmias B, Tedde A, Guarnieri BM, et al. Analysis of apolipoprotein E, alpha1-antichymotrypsin and presenilin-1 genes polymorphisms in dementia caused by normal pressure hydrocephalus in man. Neurosci Lett. 1997;229(3):177-80. (Pubitemid 27316075)
19. Li X, Miyajima M, Mineki R, Taka H, Murayama K, Arai H. Analysis of potential diagnostic biomarkers in cerebrospinal fluid of idiopathic normal pressure hydrocephalus by proteomics. Acta Neurochir (Wien). 2006;148(8):859-64; discussion 864. (Pubitemid 44126080)
20. Messmer-Joudrier S, Sagot Y, Mattenberger L, James RW, Kato AC. Injury-induced synthesis and release of apolipoprotein E and clusterin from rat neural cells. Eur J Neurosci. 1996;8(12): 2652-61. (Pubitemid 27011342)
21. Poirier J. Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease. Trends Neurosci. 1994;17(12):525-30.
22. Arai H, Higuchi S, Sasaki H. Apolipoprotein E genotyping and cerebrospinal fluid tau protein: Implications for the clinical diagnosis of Alzheimer's disease. Gerontology. 1997;43 Suppl 1:2-10. (Pubitemid 27230642)
23. Grundke-Iqbal I, Iqbal K, Quinlan M, Tung YC, Zaidi MS, Wisniewski HM. Microtubule-associated protein tau. A component of Alzheimer paired helical filaments. J Biol Chem. 1986;261(13):6084-9. (Pubitemid 17207447)
24. Grundke-Iqbal I, Iqbal K, Tung YC, Wang GP, Wisniewski HM. Alzheimer paired helical filaments: cross-reacting polypeptide/s normally present in brain. Acta Neuropathol. 1985;66(1):52-61. (Pubitemid 15138009)